In light of today's revelations from the National Cancer Institute all investors should feel secure having invested in one of the ONLY MMJ stocks that is actually going thru trials to prove the safety and effectiveness of it's products. Once the IRB safety trial is reported as successfully completed I believe that they will serve as a major catalyst for the pps to move northward and continue to do so over time with more trials, especially with our sublingual soluble tablets. Easily a double digit stock and possibly a triple longer term. All IMO of course.

https://www.cancer.gov/about-cancer/treatment...topics-pdq

https://www.cancer.gov/about-cancer/treatment...nabis-pdq/